Bryan Dechairo Biography and Net Worth

COO of GeneDx

Bryan Dechairo serves as the Chief Operating Officer at GeneDx. In his role Bryan oversees the company’s Product & Technology, Operations, Medical Affairs, Innovation, and Program Management teams. He is responsible for driving operational excellence as the company enters the next phase of commercial growth.

Bryan brings over 30 years of experience in exploratory and commercial diagnostic businesses, driving the development of revenue-generating clinical innovations that enhance patient outcomes. He most recently served as President and CEO of Sherlock Biosciences, where he successfully transformed the company from a research-stage start-up into a commercial operation. Bryan has also held executive leadership roles at prominent diagnostic and pharmaceutical companies, including Pfizer, Myriad Genetics, Assurex, Medco Health and others. Bryan holds a PhD in Human Genetics from the University College of London and a BA in Integrative Biology from the University of California Berkeley.

What is Bryan Dechairo's net worth?: The estimated net worth of Bryan Dechairo is at least $496.90 thousand as of February 2nd, 2026. Dechairo owns 5,961 shares of GeneDx stock worth more than $496,897 as of February 6th. This net worth evaluation does not reflect any other assets that Dechairo may own. Learn More about Bryan Dechairo's net worth.
How do I contact Bryan Dechairo?: The corporate mailing address for Dechairo and other GeneDx executives is 333 Ludlow Street North Tower 8th Floor, Stamford CT, 06902. GeneDx can also be reached via phone at 800-298-6470 and via email at [email protected]. Learn More on Bryan Dechairo's contact information.
Has Bryan Dechairo been buying or selling shares of GeneDx?: During the last quarter, Bryan Dechairo has sold $339,695.89 in GeneDx stock. Most recently, Bryan Dechairo sold 3,413 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $99.53, for a transaction totalling $339,695.89. Following the completion of the sale, the chief operating officer now directly owns 5,961 shares of the company's stock, valued at $593,298.33. Learn More on Bryan Dechairo's trading history.
Who are GeneDx's active insiders?: GeneDx's insider roster includes Shawn Assad (CAO), Daniel Clark (General Counsel), James Coffin (COO), Bryan Dechairo (COO), Kevin Feeley (CFO), Keith Meister (Director), Richard Pfenniger, Jr. (Director), Richard Pfenniger, Jr. (Director), Anthony Prentice (Insider), Isaac Ro (CFO), Joshua Ruch (Director), Jason Ryan (Chairman of the Board), Eric Schadt (CEO), and Katherine Stueland (CEO). Learn More on GeneDx's active insiders.
Are insiders buying or selling shares of GeneDx?: In the last year, GeneDx insiders bought shares 1 times. They purchased a total of 100,000 shares worth more than $5,601,000.00. In the last year, insiders at the sold shares 35 times. They sold a total of 781,176 shares worth more than $92,214,619.72. The most recent insider tranaction occured on February, 2nd when COO Bryan Dechairo sold 3,413 shares worth more than $339,695.89. Insiders at GeneDx own 29.6% of the company. Learn More about insider trades at GeneDx.
Information on this page was last updated on 2/2/2026.

Bryan Dechairo Insider Trading History at GeneDx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/2/2026	Sell	3,413	$99.53	$339,695.89	5,961

Bryan Dechairo Buying and Selling Activity at GeneDx

GeneDx Company Overview

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Today's Range

Now: $83.36

$81.55

$87.84

50 Day Range

MA: $127.79

$84.08

$166.77

2 Week Range

Now: $83.36

$55.17

$170.87

Volume

464,606 shs

Average Volume

744,436 shs

Market Capitalization

$2.41 billion

P/E Ratio

917.39

Dividend Yield

N/A

Bryan Dechairo Biography and Net Worth

What is Bryan Dechairo's net worth?

How do I contact Bryan Dechairo?

Has Bryan Dechairo been buying or selling shares of GeneDx?

Who are GeneDx's active insiders?

Are insiders buying or selling shares of GeneDx?